Literature DB >> 10451496

CD34 expression as a novel marker of transformed mesangial cells in biopsied glomerular diseases.

K Naruse1, M Fujieda, E Miyazaki, Y Hayashi, N Kuroda, H Nakayama, H Kiyoku, M Hiroi, T Kurashige, H Enzan.   

Abstract

CD34 is a marker of haematopoietic progenitor cells, stromal precursors, vascular endothelial cells, and a variety of stromal tumour cells. This immunohistochemical study examined the CD34 expression of glomerular mesangial cells in normal and diseased glomeruli and compared it with the staining patterns of alpha-smooth muscle actin (ASMA), as a transformed mesangial cell marker, and CD31, as an endothelial cell marker. In addition, the CD34 and ASMA expression of mesangial cells in various glomerulonephritis and the relationship of the immunostaining intensity to the severity of IgA nephropathy were semiquantitatively evaluated. In normal glomeruli, all cell types were negative for CD34, but in glomeruli in mesangial proliferative glomerulonephritis, CD34 was expressed exclusively in mesangial cells, corresponding to ASMA expression. The dendritic and scattered staining pattern, the mesangial location of positive signals, and the enhanced expression were clearly different from CD31 expression in diseased glomeruli. In comparison with normal controls, the grade of immunostaining for CD34 (CD34 INDEX) in mesangial proliferative glomerular diseases was higher than that of ASMA (ASMA INDEX). With the severity of glomerulonephritis, the CD34 INDEX gradually increased. These studies indicate that CD34 is a useful marker of mesangial transformation and that immunohistochemical examination with the anti-CD34 antibody is useful for the diagnosis and stage determination of glomerular diseases. Copyright 1999 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10451496     DOI: 10.1002/(SICI)1096-9896(199909)189:1<105::AID-PATH388>3.0.CO;2-0

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  8 in total

1.  Src family kinase involvement in rat preglomerular microvascular contractile and [Ca2+]i responses to ANG II.

Authors:  Qi Che; Pamela K Carmines
Journal:  Am J Physiol Renal Physiol       Date:  2004-11-30

Review 2.  Hematopoietic stem cells are pluripotent and not just "hematopoietic".

Authors:  Makio Ogawa; Amanda C LaRue; Meenal Mehrotra
Journal:  Blood Cells Mol Dis       Date:  2013-02-27       Impact factor: 3.039

3.  What is the significance of CD34 immunostaining in the extraglomerular and intraglomerular mesangium?

Authors:  Cristina Gluhovschi; Gheorghe Gluhovschi; Elena Potencz; Diana Herman; Ligia Petrica; Silvia Velciov; Gheorghe Bozdog; Flaviu Bob; Corina Vernic; Daniel Cioca
Journal:  Virchows Arch       Date:  2008-08-08       Impact factor: 4.064

Review 4.  Origin of renal cell carcinomas.

Authors:  Manuel Valladares Ayerbes; Guadalupe Aparicio Gallego; Silvia Díaz Prado; Paula Jiménez Fonseca; Rosario García Campelo; Luis Miguel Antón Aparicio
Journal:  Clin Transl Oncol       Date:  2008-11       Impact factor: 3.405

5.  Glomerular CD34 expression in short- and long-term diabetes.

Authors:  Luz Marina Acevedo; Irene Londono; Malika Oubaha; Lucian Ghitescu; Moise Bendayan
Journal:  J Histochem Cytochem       Date:  2008-03-03       Impact factor: 2.479

6.  Swimming exercise prevents fibrogenesis in chronic kidney disease by inhibiting the myofibroblast transdifferentiation.

Authors:  Chiung-Chi Peng; Kuan-Chou Chen; Chiu-Lan Hsieh; Robert Y Peng
Journal:  PLoS One       Date:  2012-06-27       Impact factor: 3.240

7.  The severity of glomerular endothelial cell injury is associated with infiltrating macrophage heterogeneity in endocapillary proliferative glomerulonephritis.

Authors:  Momoko Arai; Akiko Mii; Tetsuya Kashiwagi; Akira Shimizu; Yukinao Sakai
Journal:  Sci Rep       Date:  2021-06-25       Impact factor: 4.379

8.  Morphofunctional renal alterations in rats induced by intrauterine hyperglycemic environment.

Authors:  Nathane França-Silva; Natácia Dreyce Gonçalves Oliveira; Ana Paula Coelho Balbi
Journal:  Arch Med Sci       Date:  2015-04-09       Impact factor: 3.318

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.